Sign in
Taking peopleNo phase

Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility

Key facts

Who runs it
Turku University Hospital
Where
Finland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
6,000 people, planned
Started
27 Oct 2025
Planned end
31 Mar 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Possibility to get live attenuated nasal influenza vaccine at daycare
Record updated
22 January 2026

Who can take part

Age
2 years to 6 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Attending early childhood education (daycare) in the city of Turku

Who cannot take part

  • No exclusion criteria

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 2 and 6 years old?

This trial is currently available in Finland.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this intervention study is to learn if giving children influenza vaccinations in early childhood education facilities (i.e., daycare) will increase vaccination coverage compared to giving vaccinations only at healthcare. The main question it aims to answer is:

Read full original descriptionShow less

• Does offering children nasal influenza vaccine in daycare result in higher proportion of children getting influenza vaccine.

Researchers will compare daycare setting and healthcare setting as the location of giving influenza vaccines to children to see if more children will get vaccinated if they have an opportunity to receive nasal influenza vaccine at daycare.

Participants in the intervention group will:

• Have the opportunity to receive influenza vaccine in the daycare or in the healthcare

Participants in the comparison group will:

• Have the opportunity to receive influenza vaccine in the healthcare only

The 2 groups in the trial

  • Intervention groupTreatment being tested

    Participants are offered a nasal influenza vaccine at daycare

    Treatment: Possibility to get live attenuated nasal influenza vaccine at daycare

  • Comparison groupNo study treatment, for comparison

    Participants are not offered a nasal influenza vaccine at daycare

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07310472, who can take part
Record updated
22 January 2026